AROI-ESTRO GYN Teaching Course

RetroEMBRACE outcome data  Primary Objective: Local control in IGABT within multi-institutional frame prior to EMBRACE study  12 institutions participating January 1998 - August 2012  852 patients included, 49 excluded for unknown disease status and 72 excluded due to adjuvant therapy, 731 analyzed  2 IA (0.3%), 123 IB (16.8%), 42 IIA (5.7%), 368 IIB (50.3%), 23 IIIA (3.1%), 145 IIIB (19.8%), 23 stage IVA (3.1%), 5 IVB (0.7%)

 Median width at diagnosis: 50 mm clinical, 46 mm at MRI examination

 Nodal status : N+ 40%, N- 60%

THÈME DU DIAPORAMA Sturdza Radiother Oncol 2016;120:428-33

GUSTAVE ROUSSY